Variant report
Variant | nsv874314 |
---|---|
Chromosome Location | chr2:76548341-76598587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:76545602..76547142-chr2:76580181..76582795,2 | K562 | blood: | |
2 | chr2:76594575..76597450-chr2:76598327..76600856,3 | K562 | blood: | |
3 | chr2:76593394..76597450-chr2:76597715..76600856,5 | K562 | blood: | |
4 | chr2:76594575..76597450-chr2:76598327..76600856,3 | K562 | blood: | |
5 | chr2:76542822..76545873-chr2:76546426..76549641,3 | K562 | blood: | |
6 | chr2:76593394..76597450-chr2:76597715..76600856,5 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542751064 | chr2:76549638-76549639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561472617 | chr2:76549642-76549643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139081303 | chr2:76549647-76549648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112549092 | chr2:76549669-76549670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527240566 | chr2:76549734-76549735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs72923560 | chr2:76549777-76549778 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs531019726 | chr2:76549847-76549848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11896158 | chr2:76549880-76549881 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs146023364 | chr2:76549896-76549897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546370126 | chr2:76549948-76549949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569418249 | chr2:76549954-76549955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539760327 | chr2:76549957-76549958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540256372 | chr2:76550028-76550029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572904038 | chr2:76550098-76550099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565207490 | chr2:76550102-76550103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540191948 | chr2:76550106-76550107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182757305 | chr2:76550120-76550121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139927963 | chr2:76550128-76550129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550722719 | chr2:76550196-76550197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374000803 | chr2:76550210-76550211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149709058 | chr2:76550226-76550227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562559454 | chr2:76550297-76550298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10171569 | chr2:76550331-76550332 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs56053575 | chr2:76550348-76550349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs556388358 | chr2:76550388-76550389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs548798113 | chr2:76550393-76550394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76512573 | chr2:76550398-76550399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527575243 | chr2:76550401-76550402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549046081 | chr2:76550458-76550459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377551200 | chr2:76550511-76550512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567233362 | chr2:76550519-76550520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531341812 | chr2:76550532-76550533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534579043 | chr2:76550614-76550615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549812036 | chr2:76550646-76550647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188592196 | chr2:76550661-76550662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539597618 | chr2:76550687-76550688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192956459 | chr2:76550729-76550730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145249826 | chr2:76550739-76550740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534214864 | chr2:76550744-76550745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555368335 | chr2:76550753-76550754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185678674 | chr2:76550754-76550755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34466977 | chr2:76550756-76550757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537977319 | chr2:76550758-76550759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148756602 | chr2:76550774-76550775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544653179 | chr2:76550805-76550806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577774641 | chr2:76550840-76550841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545265427 | chr2:76550860-76550861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560386508 | chr2:76550867-76550868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142334848 | chr2:76550892-76550893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542929132 | chr2:76550915-76550916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76549600-76551200 | Enhancers | Fetal Brain Male | brain |
2 | chr2:76550200-76551200 | Enhancers | Fetal Brain Female | brain |
3 | chr2:76550600-76551000 | Enhancers | Hela-S3 | cervix |
4 | chr2:76551200-76552800 | Weak transcription | Fetal Brain Male | brain |
5 | chr2:76552800-76553000 | Enhancers | Fetal Brain Male | brain |
6 | chr2:76557000-76557400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr2:76577800-76578800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:76578400-76579200 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
9 | chr2:76578800-76584000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr2:76579200-76581600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
11 | chr2:76580600-76582200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr2:76581000-76581400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:76581600-76582000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr2:76581600-76582000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr2:76584000-76584800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr2:76584200-76584600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr2:76584600-76584800 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
18 | chr2:76584800-76586600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr2:76595800-76596000 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr2:76596000-76604600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |